305 related articles for article (PubMed ID: 18824423)
1. Diffusion-weighted magnetic resonance imaging in neck lymph adenopathy.
Vandecaveye V; De Keyzer F; Hermans R
Cancer Imaging; 2008 Sep; 8(1):173-80. PubMed ID: 18824423
[TBL] [Abstract][Full Text] [Related]
2. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.
Vandecaveye V; De Keyzer F; Vander Poorten V; Dirix P; Verbeken E; Nuyts S; Hermans R
Radiology; 2009 Apr; 251(1):134-46. PubMed ID: 19251938
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning.
Dirix P; Vandecaveye V; De Keyzer F; Op de Beeck K; Poorten VV; Delaere P; Verbeken E; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):761-6. PubMed ID: 19540069
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI in head and neck cancer.
Hermans R; Vandecaveye V
JBR-BTR; 2007; 90(4):264-7. PubMed ID: 17966242
[TBL] [Abstract][Full Text] [Related]
5. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.
Holzapfel K; Duetsch S; Fauser C; Eiber M; Rummeny EJ; Gaa J
Eur J Radiol; 2009 Dec; 72(3):381-7. PubMed ID: 18995981
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of diffusion-weighted MRI with STIR-EPI in differential diagnosis of cervical lymph nodes].
Zhang Y; Liang BL; Gao L; Zhong JL; Ye RX; Shen J
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):70-3. PubMed ID: 17575700
[TBL] [Abstract][Full Text] [Related]
7. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
[TBL] [Abstract][Full Text] [Related]
8. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
Giannarini G; Petralia G; Thoeny HC
Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted MR imaging in the head and neck.
Thoeny HC; De Keyzer F; King AD
Radiology; 2012 Apr; 263(1):19-32. PubMed ID: 22438440
[TBL] [Abstract][Full Text] [Related]
10. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging.
Ljumanovic R; Langendijk JA; Hoekstra OS; Leemans CR; Castelijns JA
Eur J Radiol; 2006 Oct; 60(1):58-66. PubMed ID: 16829010
[TBL] [Abstract][Full Text] [Related]
11. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
12. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient.
Nakayama J; Miyasaka K; Omatsu T; Onodera Y; Terae S; Matsuno Y; Cho Y; Hida Y; Kaga K; Shirato H
J Comput Assist Tomogr; 2010 Jan; 34(1):1-8. PubMed ID: 20118713
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted magnetic resonance imaging of head and neck.
Razek AA
J Comput Assist Tomogr; 2010; 34(6):808-15. PubMed ID: 21084893
[TBL] [Abstract][Full Text] [Related]
14. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
[TBL] [Abstract][Full Text] [Related]
15. Apparent diffusion coefficient values of necrotic and solid portion of lymph nodes: differential diagnostic value in cervical lymphadenopathy.
Zhang Y; Chen J; Shen J; Zhong J; Ye R; Liang B
Clin Radiol; 2013 Mar; 68(3):224-31. PubMed ID: 22316593
[TBL] [Abstract][Full Text] [Related]
16. Value of magnetic resonance imaging for nodal staging in patients with head and neck squamous cell carcinoma: a meta-analysis.
Wu LM; Xu JR; Liu MJ; Zhang XF; Hua J; Zheng J; Hu JN
Acad Radiol; 2012 Mar; 19(3):331-40. PubMed ID: 22153656
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
[TBL] [Abstract][Full Text] [Related]
18. The role of diffusion-weighted magnetic resonance imaging in the diagnosis, lymph node staging and assessment of treatment response of head and neck cancer.
Payne KF; Haq J; Brown J; Connor S
Int J Oral Maxillofac Surg; 2015 Jan; 44(1):1-7. PubMed ID: 25442741
[TBL] [Abstract][Full Text] [Related]
19. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
20. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.
King AD; Chow KK; Yu KH; Mo FK; Yeung DK; Yuan J; Bhatia KS; Vlantis AC; Ahuja AT
Radiology; 2013 Feb; 266(2):531-8. PubMed ID: 23151830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
